Targeted Oncology™ Community Case Forum™
Tuesday, October 7, 2025 | 5:45 - 8:30 PM ET
Sheraton & Le Méridien Charlotte Complex | Charlotte, NC
CONNECT WITH THE COMMUNITY
The Community Case Forum is a special opportunity to gather IN-PERSON only.
No virtual options are available.
After arriving at registration check-in, you'll spend some time networking with peers while enjoying small plate refreshments and cocktails. Case-based discussions will follow the networking reception and the evening will adjourn by 8:30 PM.
Eligibility
Participants must be medical oncologists or hematologists currently treating patients in a community practice setting. With prior approval from our registration team, a small number of fellows and advanced practice providers may be eligible to attend.
Discussion Topic
Our moderator will present case-based clinical profiles to generate discussion among participants around recent clinical data and potential treatment strategies.
Discussion Topic:
First-Line Therapy for Metastatic RCC: Optimizing Use of ICI-TKI Combination Regimens
During this conversation, we will explore two cases that will allow us to share perspectives on first-line use of immune checkpoint inhibitor plus tyrosine kinase inhibitor combination regimens for advanced clear cell, with a practical focus on evidence-based treatment planning, patient counseling, and treatment-related adverse event mitigation, with the ultimate goal of optimizing outcomes for our patients.
Moderated by: Sundhar Ramalingam, MD (Duke University Medical Center)
MARKET RESEARCH PARTICIPATION
Seating is limited, and registration will close when capacity is reached.
Reserve your seat today for the Targeted Oncology Community Case Forum.
Presented in Partnership With:
Targeted Healthcare Communications® — an MJH Life Sciences® Brand
259 Prospect Plains Rd., Building H, Monroe, NJ 08831
Copyright 2025 © Intellisphere, LLC. All Rights Reserved.